Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating AFib.

The procedure was carried out by Orlando Health Heart and Vascular Institute cardiothoracic surgeon Dr Anthony Rongione.

Trial will evaluate the safety and effectiveness of the AtriCure Isolator® Synergy™ EnCompass® clamp and AtriClip® Left ...

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy technologies.

Atricure, Inc. (($ATRC)) announced an update on their ongoing clinical study. Study Overview: The BoxX-NoAF Clinical Trial, officially titled ...

Bristol Vet Specialists has launched a new surgical procedure for dogs with mitral valve disease (MVD). The procedure, called ...